Skip to main content
. Author manuscript; available in PMC: 2013 Jun 1.
Published in final edited form as: Exp Neurol. 2011 Oct 28;235(2):455–463. doi: 10.1016/j.expneurol.2011.10.015

Table 1.

All RNAs in the dataset, divided by size class and treatment group.

Length Group Unique
Seq
Seq
Counts
p-value
15–17 nose-poke 8244 2744.57 7.25E-08**
15–17 pseudo-training 8244 2052.58
15–17 training 8244 1778.35 0.0069**
20–23 nose-poke 34801 14820.52 0.0036**
20–23 pseudo-training 34801 20440.43
20–23 training 34801 23633.06 4.59E-07**
25–30 nose-poke 6410 703.23 0.436
25–30 pseudo-training 6410 666.31
25–30 training 6410 43269.34 7.99E-07**
31–35 nose-poke 219 19.5 2.20E-05**
31–35 pseudo-training 219 59.62
31–35 training 219 2153.03 0.017*

Shown are the total number of unique sequences and total number of normalized sequence counts in each size class for each treatment group. Training and nose-poke groups are each compared to the pseudo-training control group.

*

p < 0.05 by t-test.

**

p < 0.01 by t-test.

Reprinted from Smalheiser et al (2011a) with permission.